This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Yongchan Kim: Innovator in Immune Tolerance
Introduction
Yongchan Kim is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunology, particularly in the development of antigen-specific T cells aimed at inducing immune tolerance. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Yongchan Kim's latest patents focus on innovative methods for targeting antigen-specific B cells using engineered T cells. These include regulatory T cells and cytotoxic T cells, as well as bi-specific antibodies. The agents and methods described in his patents are designed to reduce undesirable immune responses, showcasing his commitment to improving patient outcomes.
Career Highlights
Yongchan Kim is affiliated with The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work there emphasizes the importance of research in military medicine and its applications in broader healthcare contexts. His contributions are vital in addressing complex immune challenges.
Collaborations
Some of his notable coworkers include David W. Scott and Aihong Zhang. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Yongchan Kim's work in the realm of immune tolerance is crucial for the future of immunotherapy. His patents and collaborations reflect a dedication to advancing medical science and improving health outcomes.